Why a 6 cm Non-Mass Enhancement is Described as "Focal"
The term "focal" in breast MRI refers to the distribution pattern of non-mass enhancement, not its absolute size—a 6 cm area can be "focal" if it occupies a single confined region within one quadrant of the breast, as opposed to being scattered across multiple quadrants or diffusely distributed throughout the breast. 1
Understanding BI-RADS MRI Distribution Terminology
The confusion arises from conflating two distinct concepts: the spatial extent (measured in centimeters) versus the distribution pattern (a categorical descriptor). 2
Distribution Categories for Non-Mass Enhancement
The BI-RADS MRI lexicon classifies non-mass enhancement distribution into six patterns 2, 3:
- Focal: Enhancement in a single confined area within one quadrant
- Linear: Enhancement arranged in a line
- Segmental: Enhancement in a ductal/triangular distribution pointing toward the nipple
- Regional: Enhancement occupying a larger geographic area without conforming to ductal distribution
- Multiple regions: Enhancement in multiple separate areas
- Diffuse: Enhancement scattered throughout the breast
A 6 cm enhancement is called "focal" when it represents a single, geographically confined abnormality within one quadrant, even though 6 cm is objectively large. 3, 4 The term distinguishes it from "regional" (which would be even more extensive within a quadrant), "multiple regions" (separate areas in different quadrants), or "diffuse" (scattered throughout). 5
Clinical Significance of This Distinction
Malignancy Risk Stratification
"Focal" distribution carries intermediate malignancy risk compared to other patterns—significantly higher than "diffuse" but lower than "segmental" or "linear" patterns. 4, 5
- Segmental distribution shows the highest positive predictive value for malignancy (p < 0.001) 4
- Focal distribution is a significant predictor of malignancy (p = 0.006) 5
- Multiple regions and diffuse patterns are more commonly benign 3
Size Still Matters Independently
Despite the "focal" descriptor, the 6 cm size itself is a critical independent predictor of malignancy—lesions ≥1 cm are significantly more likely to be malignant than smaller lesions (p < 0.0001). 5 In multivariate analysis, lesion size ≥1 cm was the only significant independent predictor of malignancy for non-mass enhancement. 5
Practical Implications for Management
Why This Terminology Matters
The combination of "focal" distribution with 6 cm extent creates a high-risk scenario requiring tissue diagnosis, as MRI tends to overestimate DCIS extent by 1.97–3.2 cm on average, meaning substantial disease is still likely present. 1, 6
This large focal enhancement markedly increases the likelihood of multifocal/multicentric disease and potential upgrade to invasive cancer. 1
Management Algorithm
MRI-guided core needle biopsy is the definitive next step for this 6 cm focal non-mass enhancement visible only on MRI. 1
Prior to MRI-guided biopsy:
- Perform second-look targeted ultrasound to identify a possible sonographic correlate that would allow ultrasound-guided biopsy (more accessible and technically easier) 1
- Obtain diagnostic mammography with tomosynthesis to evaluate for associated calcifications or architectural distortion 1
Observation without tissue diagnosis is inappropriate for a 6 cm lesion, regardless of enhancement kinetics or pattern. 1
Common Pitfalls to Avoid
Do not be falsely reassured by "focal" terminology—the 6 cm size overrides any reassurance the distribution pattern might suggest. 1, 5
Do not rely on kinetic curves to downgrade suspicion—DCIS-related non-mass enhancement often shows medium or persistent kinetic curves (not washout), which can falsely reassure clinicians. 1, 6 Kinetic patterns are not significant predictors of malignancy for non-mass enhancement. 5
Even "probably benign" appearing non-mass enhancement of this extent requires histologic confirmation because of the potential for extensive DCIS. 1